HEALTH TRAIN EXPRESS Mission: To promulgate health education across the internet: Follow or subscribe to Health Train Express as well as Digital Health Space for all the updates for health policy, reform, public health issues. Health Train Express is published several times a week.Subscribe and receive an email alert each time it is published. Health Train Express has been published since 2006.
Listen Up
Saturday, February 19, 2022
Perspectives from the Frontline of the Fight for Public Health: A Live Q...
Tuesday, February 15, 2022
FAKE NEWS ? Psilocybin treatment for major depression effective for up to a year for most patients - ScienceBlog.com
Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.
A compound found in so-called magic mushrooms, psilocybin produces visual and auditory hallucinations and profound changes in consciousness over a few hours after ingestion. In 2016, Johns Hopkins Medicine researchers first reported that treatment with psilocybin under psychologically supported conditions significantly relieved existential anxiety and depression in people with a life-threatening cancer diagnosis.A report on the new study was published on Feb. 15, 2022 in the Journal of Psychopharmacology.
The study was done under carefully controlled scientific studies by professional monitors who sat side-by-side with the patient.
Thursday, February 10, 2022
It isn't easy being green
"It isn't easy being green." Kermit, the frog
Why are some potato chips green? are some potato chips green?
Few people will happily eat the green crisp - but here's the amount you'd have to eat to get ill, and what causes them.
Why are some potato chips green? — Tasting Table
Wednesday, February 9, 2022
Sunlight: Optimize Health and Immunity (Light Therapy and Melatonin)
Monday, February 7, 2022
Goldie Hawn Opens Up About Her Childhood Depression & The Importance of ...
Sunday, February 6, 2022
Hobby Tool | Find New Activities to Replace Gaming
Parent Guides from ConnectSafely
Hobby Tool | Find New Activities to Replace Gaming
Thursday, February 3, 2022
META and SNAPCHAT are sued by parent of 11 year old who committed suicide.
Are Meta Platforms Inc. and Snap Inc. to blame for the suicide of an 11-year-old who suffered from depression and sleep deprivation after becoming addicted to Instagram and Snapchat, the girl’s mother alleged in a lawsuit.
If the parent prevails in this case it would be a huge precedent-setting case, not dissimilar to the Perdue opioid settlement for opioids.
The case will require evidence from experts in addictive behavior. Some neuroscientists have published evidence (Andrew Doan, MD, Ph.D.). Dr. Doan is an ophthalmologist, whose Ph.D. thesis included addictive behavior in video gamers. He also authored "Hooked on Games"
The complaint appears to be the first of its kind against Meta, formerly known as Facebook Inc., said attorney Matthew Bergman, who founded Social Media Victims Law Center in Seattle and represents Rodriguez’s mother.
“There is a mental health epidemic among American teens,” Bergman said. He added that he anticipates a significant number of similar cases will be filed after a former Facebook employee turned whistle-blower testified in Congress in October that the company knew about, but didn’t disclose, the harmful impacts of services like Instagram.
This is unacceptable behavior behind the curtain of 'freedom of speech' and unaccountability. Despite Meta and Snapchat's disavowal of responsibility, there is a growing concern about their effect on morals. Young children's perception of reality becomes confused with virtual reality during their formative years.
Unguided children self treat their anxiety and fear on the internet.
Tuesday, February 1, 2022
Potpourri of Healthy Eating Habits
Slowing the Aging Process: Two Blood Proteins Could Be Key to a Long and Healthy Life
Two blood proteins have been shown by scientists to influence how long and healthy a life we live, research suggests.
Developing drugs that target these proteins could be one way of slowing the aging process, according to the largest genetic study of aging.
As we age, our bodies begin to decline after we reach adulthood, which results in age-related diseases and death. This latest research investigates which proteins could influence the aging process.
Many complex and related factors determine the rate at which we age and die, and these include genetics, lifestyle, environment, and chance. The study sheds light on the part proteins play in this process.
Some people naturally have higher or lower levels of certain proteins because of the DNA they inherit from their parents. These protein levels can, in turn, affect a person’s health.
University of Edinburgh researchers combined the results of six large genetic studies into human aging – each containing genetic information on hundreds of thousands of people,
Among 857 proteins studied, researchers identified two that had significant negative effects across various aging measures.
People who inherited DNA that causes raised levels of these proteins were frailer, had poorer self-rated health, and were less likely to live an exceptionally long life than those who did not.
The first protein, called apolipoprotein(a) (LPA), is made in the liver and thought to play a role in clotting. High levels of LPA can increase the risk of atherosclerosis – a condition in which arteries become clogged with fatty substances. Heart disease and stroke are possible outcomes.
The second protein, vascular cell adhesion molecule 1 (VCAM1), is primarily found on the surfaces of endothelial cells – a single-cell layer that lines blood vessels. The protein controls vessels’ expansion and retraction – and function in blood clotting and the immune response.
Levels of VCAM 1 increase when the body sends signals to indicate it has detected an infection, VCAM1 then allows immune cells to cross the endothelial layer, as seen for people who have naturally low levels of these proteins.
The researchers say that drugs used to treat diseases by reducing levels of LPA and VCAM1 could have the added benefit of improving quality and length of life.
One such example is a clinical trial that is testing a drug to lower LPA as a way of reducing the risk of heart disease.
There are currently no clinical trials involving VCAM1, but studies in mice have shown how antibodies lowering this protein’s level improved cognition during old age.
The findings have been published in the journal Nature Aging.
Dr. Paul Timmers, lead researcher at the MRC Human Genetics Unit at the University of Edinburgh, said: “The identification of these two key proteins could help extend the healthy years of life. Drugs that lower these protein levels in our blood could allow the average person to live as healthy and as long as individuals who have won the genetic lottery and are born with genetically low LPA and VCAM1 levels.”
Professor Jim Wilson, Chair of Human Genetics at the University of Edinburgh’s Usher Institute, said: “This study showcases the power of modern genetics to identify two potential targets for future drugs to extend lifespan.”
Reference: “Mendelian randomization of genetically independent aging phenotypes identifies LPA and VCAM1 as biological targets for human aging” by Paul R. H. J. Timmers, Evgeny S. Tiys, Saori Sakaue, Masato Akiyama, Tuomo T. J. Kiiskinen, Wei Zhou, Shih-Jen Hwang, Chen Yao, Biobank Japan Project, FinnGen, Joris Deelen, Daniel Levy, Andrea Ganna, Yoichiro Kamatani, Yukinori Okada, Peter K. Joshi, James F. Wilson and Yakov A. Tsepilov, 20 January 2022, Nature Aging.
DOI: 10.1038/s43587-021-00159-8
Drinking This Before Bed May Help You Sleep (And It's Not Warm Milk)
If you need to take beta-blockers, consider taking melatonin supplements.
And finally here are.
50 Tips for Sleeping Better Tonight, According to Experts
Expert Newsletters - Cardio Prevention, Covid 19
A weekly collection focused on cardio prevention
Joel Kahn, MD, FACC of Detroit, Michigan, is a practicing cardiologist, and a Clinical Professor of Medicine at Wayne State University School of Medicine. He graduated Summa Cum Laude from the University of Michigan Medical School. Known as "America’s Healthy Heart Doc", Dr. Kahn has triple board certification in Internal Medicine, Cardiovascular Medicine, and Interventional Cardiology. He was the first physician in the world to certify in Metabolic Cardiology with A4M/MMI and the University of South Florida. He founded the Kahn Center for Cardiac Longevity in Bingham Farms, MI. Dr. Kahn has authored scores of publications in his field including articles, book chapters and monographs. He writes health articles and has 6 books in publication including Your Whole Heart Solution, Dead Execs Don’t Get Bonuses and The Plant-Based Solution, and Lipoprotein(a): The Heart’s Silent Killer. He has regular appearances on Dr. Phil, The Doctors Show, Dr. Oz, Larry King Now, Joe Rogan Experience, and with Bassem Yousef. He has been awarded a Health Hero award from Detroit Crain’s Business. He serves as medical director of the largest plant support group in the USA, www.pbnsg.org. Dr. Kahn can be found at www.drjoelkahn.com.
The Red Wine Study Many Are Raising Their Glasses Too
An analysis of the relationship of red and white wine drinking and C19 infection shows an association with benefits to raising a glass? Caution all but at least hypothesis-generating. Do you know your Lp(a) level, your patient's levels? The prognostic power of Lp(a) suggests you should as I check in 100% of my clinic visits. CIMT is a powerful tool I use routinely to track plaque and it is valid in children too. Broccoli, aging, cherry juice, and dietary epigenetics finish the list with a bowed head and a walking meditation in memory of Thich Nhat Nahn.
The study found that those who drank one to two glasses of red wine per day had between a 10 and 17 percent lower risk of getting Covid-19 when compared with teetotalers. White wine drinkers in the study who drank between one and four glasses a week reduced their risk of contracting Covid-19 by 7 to 8 percent.
Meanwhile, beer and cider drinkers increased their risk of contracting the virus by 28 percent over non-drinkers, regardless of the amount they consumed. Those who drink five or more hard alcohol drinks a week also increased their risk of infection. Heavy drinkers of all types of alcohol also had an increased risk.